2023 Specialty Day All-Access Pass-Questions and Answers

Video Transcription

Thank you. We just have a few minutes for questions because we do not want to take any time away from the meniscus session coming up next. Please invite anyone to the microphone.  Come down quickly if you can. Otherwise, can I ask just a couple of questions if there's no one from the audience? Sir, do you have a question?  Just real quick. When you were showing injecting whatever into the meniscus or injecting into  the ACL, how does that not damage the construct of it? Are you using a very small needle?  Are we worried at all? It's like having an intrameniscal cyst. Is that causing any pathology? Great question. Bert?  Yeah, we're using a small needle, and they're just small needle holes with a 21-gauge needle. So I don't really think there's any damage to the structure in and of itself.  But volume is a huge consideration, right? And so then these biologics are potent in their own right. So then filling it up and distending the collagen fibers may have detrimental  results, and I don't think that's known, but a certain consideration. Yes, sir?  My question is about the use of PRP in osteoarthritis. Is it just a biologics, or is it a regenerative medicine? PRP in osteoarthritis.  Yeah, I'm sorry. So the second part of your question, can you repeat it? Is it just a biologics, or is it a part of regenerative medicine?  Are you talking about the terminology of regenerative medicine? Yeah, definitely. So I don't think we know in osteoarthritis that we're regenerating anything. I think  in certain tendinopathies, you could look at the use of PRP and talk about what we've seen today in terms of regenerative properties. When I use the term regenerative medicine,  I do so in the same way that the NIH and the FDA uses regenerative medicine as a growing field of translational research that's becoming part of the practice of medicine. So it's  a broad, broad term, and I think what we're discussing today, specifically orthobiologics, is like a subset of regenerative medicine. Thank you.  I have one question for Lisa, if you don't mind. During your preparation for this, in backing up, I received an email two weeks ago from a company that said, you should use  our placental product. It has been just cleared by the FDA. I haven't heard anything. Have you come up with any products that have been currently FDA approved for its use, or are  we looking to the future for that? I don't know of any. OK. Yeah, Scott, same? Because you're up to it. No. OK. Yeah, interesting.  Yeah. Thank you guys very much for a wonderful session.

Video Summary

In this video, the speaker mentions that they have limited time for questions before the next session starts. They invite anyone to ask questions, and if no one does, they proceed to ask their own questions. One audience member asks about the potential damage to the meniscus when injecting substances into it, and the speaker explains that they use a small needle and do not believe there is significant damage. Another person asks about the use of PRP in osteoarthritis and whether it is considered regenerative medicine. The speaker explains that while there is limited evidence of regeneration in osteoarthritis, PRP falls under the broad umbrella of regenerative medicine. The video concludes with a question about FDA-approved products in this field, and both speakers acknowledge not being aware of any currently approved products.

Asset Caption

Moderator: Jason L. Dragoo, M.D., FAANA

Keywords

limited time

questions

meniscus

PRP

regenerative medicine